pharmaceutical-technology.com
51%
497
Japan’s Daiichi Sankyo in talks with AstraZeneca for Covid-19 vaccine
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Japanese pharmaceutical company Daiichi Sankyo has entered an agreement for discussions with AstraZeneca for the supply of a Covid-19 vaccine candidate, being developed in alliance with the University of Oxford, in Japan. Daiichi Sankyo said that AstraZeneca has agreed for specific talks with the Japanese government regarding the introduction of the vaccine candidate in Japan.